NCTR Research Highlights
Current Highlight from November 14, 2014
Progress on FDA Studies Reviewed
The 44th meeting of the Toxicology Study Selection and Review Committee (TSSRC) was held November 12-13, 2014, at FDA’s White Oak facility, to discuss ongoing studies that are part of the Interagency Agreement between FDA/NCTR and the National Institute of Environmental Health Sciences/National Toxicology Program (NIEHS/NTP) that supports toxicology studies providing data for the FDA risk assessment process.
Ongoing studies at NCTR in the following areas were discussed:
- Food contaminants (Bisphenol A; melamine + cyanuric acid; nanosilver)
- Topically applied compounds (retinyl palmitate; oxybenzone)
- Antibacterial chemicals (triclosan)
- Medical device components (nanosilver)
- Dietary supplement component (aloe vera)
The NIEHS/NTP presented updates on the NTP and the NIEHS/NTP Toxicology Testing Program.
The TSSRC is comprised of regulatory scientists and subject-matter experts from the FDA Centers (CBER, CDER, CDRH, CFSAN, CVM, and CTP), NIEHS/NTP, and the National Institutes of Health. The committee meets twice each year and is responsible for scientific oversight of study design and progress of ongoing work under this Interagency Agreement. The next meeting of the TSSRC will be held at the FDA White Oak campus, May 6-7, 2015.
For additional information, please contact Paul C. Howard, Ph.D., Director, Office of Scientific Coordination, FDA/NCTR.
NCTR Research Highlights Archives
2014-NCTR Research Highlights 2013-NCTR Research Highlights[ARCHIVED] 2012-NCTR Research Highlights[ARCHIVED] 2011-NCTR Research Highlights[ARCHIVED] 2010-NCTR Research Highlights[ARCHIVED] 2009-NCTR Research Highlights[ARCHIVED] 2008-NCTR Research Highlights[ARCHIVED] 2007-NCTR Research Highlights[ARCHIVED] 2006-NCTR Research Highlights[ARCHIVED]
Food and Drug Administration
3900 NCTR RoadJefferson, AR 72079